Table 4 Drug resistance distribution by treatment outcome and treatment interruption groups.
Drug and its susceptibility status | Treatment outcome status, n (%) | Treatment interruption status, n (%) | |||
|---|---|---|---|---|---|
Successful | Unsuccessful | Interrupted at least one day | Never interrupted | ||
Rifampin (n = 383) | Resistant | 263 (68.7) | 120 (31.3) | 192 (50.1) | 191 (49.9) |
Susceptible | Not reported | Not reported | 12 (50.0) | 12 (50.0) | |
Isoniazid (n = 107) | Resistant | 69 (73.4) | 25 (26.6) | 51 (54.3) | 43 (45.7) |
Susceptible | 6 (46.2) | 7 (53.8) | 10 (76.9) | 3 (23.1) | |
Ethambutol (n = 18) | Resistant | 7 (77.8) | 2 (22.2) | 6 (66.7) | 3 (33.3) |
Susceptible | 3 (33.3) | 6(66.7) | 7 (77.8) | 2 (22.2) | |
Streptomycin (n = 16) | Resistant | 7 (63.6) | 4 (36.4) | 7 (63.6) | 4 (36.4) |
Susceptible | 2 (40.0) | 3 (60.0) | 5 (100.0) | 0 (0.0) | |
